fingolimod hydrochloride has been researched along with Aura in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Ali Mard, S; Farbood, Y; Ghafouri, S; Hajipour, S; Khombi Shooshtari, M; Moradi Chameh, H; Sarkaki, A; Sistani Karampour, N | 1 |
| Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M | 1 |
| Angelopoulou, E; Gnatkovsky, V; Othman, I; Paudel, YN; Piperi, C; Shaikh, MF | 1 |
| Bascuñana, P; Brackhan, M; Möhle, L; Pahnke, J | 1 |
| Farbood, Y; Ghafouri, S; Najafian, SA; Sarkaki, A | 1 |
| Citraro, R; Constanti, A; De Sarro, G; Leo, A; Marra, R; Palma, E; Paola, EDD; Russo, E | 1 |
| Chabwine, JN; Démonet, JF; du Pasquier, RA; Hirt, L; Kuntzer, T; Michel, P; Rossetti, AR; Schluep, M; Vingerhoets, FG | 1 |
4 review(s) available for fingolimod hydrochloride and Aura
| Article | Year |
|---|---|
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Ceftriaxone; Dibenzazepines; Drug Repositioning; Epilepsy; Epilepsy, Post-Traumatic; Erythropoietin; Fingolimod Hydrochloride; GABA Agents; Gabapentin; Humans; Immunologic Factors; Inflammation; Interleukin 1 Receptor Antagonist Protein; Isoflurane; Levetiracetam; Losartan; Neuroprotective Agents; Oxidative Stress; Pregabalin; Pyrrolidinones; Sirolimus; Stroke; Topiramate; Translational Research, Biomedical; Vigabatrin | 2020 |
From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Seizures; Sphingosine 1 Phosphate Receptor Modulators | 2020 |
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Fingolimod Hydrochloride; Humans; Lymphocytes; Mice; Multiple Sclerosis; Nervous System Diseases; Neuroprotective Agents; Rats; Sphingosine 1 Phosphate Receptor Modulators | 2020 |
The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment.
Topics: Animals; Epilepsy; Fingolimod Hydrochloride; Humans; Immunologic Factors; Lysophospholipids; Signal Transduction; Sphingosine | 2017 |
3 other study(ies) available for fingolimod hydrochloride and Aura
| Article | Year |
|---|---|
Fingolimod Administration Following Hypoxia Induced Neonatal Seizure Can Restore Impaired Long-term Potentiation and Memory Performance in Adult Rats.
Topics: Animals; Epilepsy; Female; Fingolimod Hydrochloride; gamma-Aminobutyric Acid; Hippocampus; Hypoxia; Long-Term Potentiation; Male; Memory Disorders; Rats; Receptors, N-Methyl-D-Aspartate; Seizures | 2023 |
FTY720 administration following hypoxia-induced neonatal seizure reverse cognitive impairments and severity of seizures in male and female adult rats: The role of inflammation.
Topics: Aging; Animals; Animals, Newborn; Cognitive Dysfunction; Epilepsy; Female; Fingolimod Hydrochloride; Hippocampus; Hypoxia; Inflammation; Male; Neuroprotective Agents; Pentylenetetrazole; Rats; Seizures; Severity of Illness Index | 2021 |
[Neurology].
Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brain Stimulation; Dopamine Agonists; Epilepsy; Fingolimod Hydrochloride; Genetic Therapy; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Multiple Sclerosis; Muscular Diseases; Neurology; Parkinson Disease; Phenylenediamines; Polyneuropathies; Propylene Glycols; Sphingosine; Stroke; Treatment Outcome; Valproic Acid | 2012 |